Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Viserion Oilseed Processing to acquire Barcelona soya crush plant from Cargill In a move set to make waves in the European commodities market, Viserion Oilseed Processing, LLC, an offshoot… byPallavi MadhirajuOctober 15, 2023